Company Filing History:
Years Active: 2007-2012
Title: Bharat Lagu - Innovator in Pharmaceutical Chemistry
Introduction
Bharat Lagu is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 7 patents. His work primarily focuses on developing innovative compounds for treating various medical conditions.
Latest Patents
Among his latest patents, Bharat has developed Dihydro-[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia, and diabetes. This invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates, and derivatives thereof, aimed at treating RXR mediated disorders. Additionally, he has created quaternary salt CCR2 antagonists, which are quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof. These compounds serve as CCR2 antagonists and are useful in preventing, treating, or ameliorating CCR2 mediated inflammatory syndromes, disorders, or diseases in subjects in need.
Career Highlights
Bharat has worked with prominent companies in the pharmaceutical industry, including Janssen Pharmaceutica and Orapharma, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in drug formulation and therapeutic applications.
Collaborations
Throughout his career, Bharat has collaborated with esteemed colleagues such as Michael P. Wachter and Rimma Lebedev. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work in the pharmaceutical sector.
Conclusion
Bharat Lagu is a distinguished inventor whose contributions to pharmaceutical chemistry have led to the development of important therapeutic compounds. His innovative work continues to influence the treatment of various medical conditions, showcasing the vital role of inventors in advancing healthcare solutions.